[177Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells
暂无分享,去创建一个
Vladimir Tolmachev | Mattias Sandström | Jörgen Carlsson | Karl Andersson | Lars Gedda | J. Carlsson | V. Tolmachev | L. Gedda | K. Andersson | M. Sandström | M. Persson | Mikael Persson
[1] N. Hynes,et al. A new therapeutic antibody masks ErbB2 to its partners. , 2004, Cancer cell.
[2] R. Burger,et al. Biomarker conservation in primary and metastatic epithelial ovarian cancer. , 2000, Gynecologic oncology.
[3] K. Wester,et al. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review , 2004, British Journal of Cancer.
[4] D. Goldenberg. Advancing role of radiolabeled antibodies in the therapy of cancer , 2003, Cancer Immunology, Immunotherapy.
[5] S. Mirzadeh,et al. Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin. , 1990, Bioconjugate chemistry.
[6] I. Pastan,et al. Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells. , 1980, The Journal of biological chemistry.
[7] Neal Rosen,et al. Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors , 2004, Nature Biotechnology.
[8] M. Brechbiel,et al. A Single Treatment of Yttrium-90-labeled CHX-A″–C6.5 Diabody Inhibits the Growth of Established Human Tumor Xenografts in Immunodeficient Mice , 2004, Cancer Research.
[9] K. Wester,et al. Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases , 2005, BJU international.
[10] Chun Xing Li,et al. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] R. Reilly,et al. Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments. , 2005, Nuclear medicine and biology.
[12] Torgny Stigbrand,et al. Tumour therapy with radionuclides: assessment of progress and problems. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] B. Karlan,et al. Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] M. Campiglio,et al. Oncogenic protein tyrosine kinases , 2004, Cellular and Molecular Life Sciences CMLS.
[15] S. Horning. Future directions in radioimmunotherapy for B-cell lymphoma. , 2003, Seminars in oncology.